In order to reveal the underlying mechanisms determining differential sensitivity to BH3 mimetics in CRC, mRNA and protein expression of BCL-2, BCL-XL, and MCL-1 were examined in all 19 CRC cell lines in untreated conditions. This evidence concerns the gene BCL2 and colorectal carcinoma.